Neuromyelitis optic spectrum disease
Conditions
Interventions
experimental group:NMOSDs conventional drug therapy +rTMS treatment group (experimental group)
control group:conventional drug therapy
Sponsors
Fujian Medical University Union Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. The clinical diagnosis conforms to the NMOSD diagnostic standard formulated by the International NMO Diagnostic Group (IPND) in 2015; 2. The age of enrollment is 18-80 years old, regardless of gender; 3. Visual Analogue (VAS)>4; 4. Understand and be willing to participate in this study and sign the informed consent form before joining the group.
Exclusion criteria
Exclusion criteria: 1. Epilepsy history or family history of epilepsy; 2. Previous craniocerebral surgery; 3. Intracranial implants; 4. Cardiac pacing implantation; 5. ECG indicates arrhythmia (sick sinus syndrome, fast supraventricular tachycardia, fast ventricular tachycardia, preexcitation syndrome, etc.); 6. Platelets below 100 × 109/L, severe liver and kidney insufficiency.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EDSS;VisualAnalogue Scale;Simple pain Questionnaire; | — |
Secondary
| Measure | Time frame |
|---|---|
| HAMA+HAMD;Patients’ Global Impression of Change Scale,PGIC); | — |
Countries
China
Contacts
Public ContactZhangJian
Fujian Medical University Union Hospital
Outcome results
None listed